- Published on:
Matanzas, Cuba, Dec. 3 (Prensa Latina) A clinical trial of the drug Jusvinza, developed by the Center for Genetic Engineering and Biotechnology (CIGB) for the treatment of residual polyarthritis in patients recovering from chikungunya, has begun in the Cuban province of Matanzas.







